ASCO GU 2021: Cabozantinib for the treatment of kidney cancer brain metastases
Brain metastases resulting from the spread of renal cell carcinoma [...]
Brain metastases resulting from the spread of renal cell carcinoma [...]
The past couple of years has seen a number of [...]
The Food and Drug Administration (FDA) in the United States has [...]
The US Food and Drug Administration (FDA) has granted the [...]
In this video interview, Dr Monty Pal from the City [...]
In this study, two doses of cabozantinib were tested in [...]
The COSMIC-021 clinical trial investigated a combination of cabozantinib and [...]
In this video interview with Dr Monty Pal from the [...]
Sarcopenia is the loss of muscle mass along with reduced [...]
This recent retrospective study included 84 patients with metastatic renal [...]